Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Hematology|May 16, 2013
Progress against follicular lymphomaJonathan H Schatz, Elisa Oricchio, Soham D Puvvada, et al.
Cold Spring Harbor Molecular Case Studies|May 11, 2017
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Amit Dipak Amin, Tara L Peters, Lingxiao Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736Deborah M Stephens, Hongli Li, Michael L LeBlanc, et al.
Oncology|April 24, 2010
NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancerSoham D Puvvada, William K Funkhouser, Kevin Greene, et al.
Oncology|September 5, 2017
A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk LymphomaSoham D Puvvada, José M Guillén-Rodríguez, Xavier I Rivera, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 24, 2017
Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent LymphomasSoham D Puvvada, José Guillen-Rodriguez, Abhijeet Kumar, et al.
Oncology|February 23, 2018
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II StudySoham D Puvvada, José M Guillén-Rodríguez, Jessica Yan, et al.
Cancer Research|May 29, 2015
Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ TumorsAmit Dipak Amin, Soumya S Rajan, Winnie S Liang, et al.
Leukemia & Lymphoma|January 14, 2016
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520Soham D Puvvada, Hongli Li, Lisa M Rimsza, et al.
British Journal of Haematology|April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Pageof 2